CRP and depressive symptom measurement: This includes prospective and genetic evidence linking elevated inflammatory signaling to depression risk (e.g., childhood IL-6/CRP predicting adult depression; IL-6 pathway Mendelian randomization), and associations with aggression-related psychopathology [61].